Peptide Synthesis Market to Grow at 6.5% CAGR to 2023 - ReportsnReports.com

News provided by

ReportsnReports

23 Jul, 2018, 14:00 GMT

PUNE, India, July 23, 2018 /PRNewswire/ --

Peptide synthesis market is projected to reach USD 426.4 million by 2023 from USD 310.5 million in 2018, at a CAGR of 6.5%. The peptide synthesis market in this report is segmented by product, technology, end user, and regions. It provides detailed information regarding major factors influencing the growth market (drivers, restraints, opportunities, and industry-specific challenges).

Major players in peptide synthesis market are GenScript Biotech Corporation (China), AAPPTec (US), Bachem (Switzerland), AnaSpec (US), Biotage (Sweden), CEM Corporation (US), Gyros Protein Technologies (Sweden), Advanced ChemTech (US), Merck KGAA (Germany) and New England Peptide (US).

Browse 92 Market Data Tables and 29 Figures spread through 135 Pages and In-depth TOC on "Peptide Synthesis Market by Product (Reagent, Synthesizer, Chromatography), Technology (Solid Phase, Liquid Phase, and Hybrid & Recombinant), End User (Pharmaceuticals & Biotechnology, CRO), and Region - Global Forecast to 2023" at http://www.reportsnreports.com/reports/1574238-peptide-synthesis-market-by-product-reagent-synthesizer-chromatography-technology-solid-phase-liquid-phase-and-hybrid-recombinant-end-user-pharmaceuticals-biotechnology-cro-and-region-global-fore-st-to-2023.html

Key Audience: 

  • Biotechnology & pharmaceutical companies
  • Market research and consulting firms
  • Venture capitalists and investors
  • Research & development companies
  • Contract research organizations (CROs)
  • Academic research institutes
  • Government institutes

Invention of peptide synthesis led to development of different application areas in which synthetic peptides are now use, including development of epitope-specific antibodies against pathogenic proteins, study of protein functions & identification & characterization of proteins. In contrast biological process of producing long peptides (proteins) is usually referred to as protein biosynthesis. In organic chemistry, peptide synthesis production of peptides, in which multiple amino acids are linked via peptide bonds.

Order Now Research Copy of "Peptide Synthesis Market by Product (Reagent, Synthesizer, Chromatography), Technology (Solid Phase, Liquid Phase, and Hybrid & Recombinant), End User (Pharmaceuticals & Biotechnology, CRO), and Region - Global Forecast to 2023" Report at http://www.reportsnreports.com/purchase.aspx?name=1574238 .

The peptide synthesis market in this report is segmented by product, technology, end user, and regions. It provides detailed information regarding major factors influencing growth market (drivers, restraints, opportunities, and industry-specific challenges). Study tracks & analyzes competitive developments (such as partnerships, agreements, collaborations, mergers & acquisitions.

The contract development and manufacturing organizations segment is projected to grow at the highest CAGR during the forecast period" 

Peptide synthesis market has been segmented into solid-phase synthesis, liquid-phase synthesis, & hybrid & recombinant technology. Solid-phase synthesis held largest share of peptide synthesis market in 2017 due to advantages like ease of operation, easy purification, short production cycles, high-level automation, and synthesis capabilities of long peptides in small quantities of amino acids.

Download the Information Sample of Global Peptide Synthesis Market Research Study Now at http://www.reportsnreports.com/contacts/requestsample.aspx?name=1574238 .

In this report, the peptide synthesis market has been segmented by product, technology, and end user. This report also provides market information based on key regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Break of primary participants was as mentioned below: 

  • By Company Type - Tier 1-45%, Tier 2-40% and Tier 3-15%
  • By Designation - C-level-41%, Director Level-30%, Others-29%
  • By Region - North America-32%, Europe-27%, Asia-Pacific-19%, Latin America-12%, Middle East & Africa- 10%

Another research titled injection pen market is expected to reach USD 41.38 billion by 2022 from an estimated USD 30.97 billion in 2017, at a CAGR of 6.0% during the forecast period. Growing prevalence of chronic diseases across the globe. The key players in the global injection pen market are Novo Nordisk (Denmark), Eli Lilly (US), and Sanofi (France), Merck (US), Ypsomed (Switzerland), AstraZeneca (UK), F.Hoffman-La Roche (Switzerland), Becton Dickinson and Company (US), Owen Mumford (UK), Novartis (Switzerland), Pfizer (US), and Haselmeier (Switzerland) and it is now available with discount at http://www.reportsnreports.com/contacts/discount.aspx?name=1367552 .

Explore More Reports on Biotechnology Market Research Available Now at http://www.reportsnreports.com/market-research/biotechnology/ .

About Us: 

ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, ReportsnReports.com offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.


Contact:
Hrishikesh Patwardhan
2nd Floor, Metropole Building,
Next to Inox Theatre,
Bund Garden Road, Pune - 411001.
Maharashtra, India.
+1-888-391-5441
sales@reportsandreports.com  

Connect with Us:  

LinkedIn: http://www.linkedin.com/company/reportsnreports
RSS/Feeds:  http://www.reportsnreports.com/feed/l-latestreports.xml